itraconazole and Ethmoid Sinusitis

itraconazole has been researched along with Ethmoid Sinusitis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E	1
Abe, N; Azuma, T; Hatta, K; Ishimaru, H; Komatsu, M; Okamoto, M	1
Arnold, G; Eckel, HE; Lackner, KJ; Stennert, E; Streppel, M	1

Reviews

1 review(s) available for itraconazole and Ethmoid Sinusitis

Article	Year
Improved outcome of zygomycosis in patients with hematological diseases? Leukemia & lymphoma, 2004, Volume: 45, Issue:7 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Deoxycholic Acid; Ethmoid Sinusitis; Female; Hematologic Diseases; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Liposomes; Lymphoma, Large B-Cell, Diffuse; Male; Maxillary Sinusitis; Middle Aged; Mucor; Mucormycosis; Multiple Myeloma; Nose Diseases; Opportunistic Infections; Prognosis; Treatment Outcome; Zygomycosis	2004

Article

Year

Improved outcome of zygomycosis in patients with hematological diseases?

Leukemia & lymphoma, 2004, Volume: 45, Issue:7

Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Deoxycholic Acid; Ethmoid Sinusitis; Female; Hematologic Diseases; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Liposomes; Lymphoma, Large B-Cell, Diffuse; Male; Maxillary Sinusitis; Middle Aged; Mucor; Mucormycosis; Multiple Myeloma; Nose Diseases; Opportunistic Infections; Prognosis; Treatment Outcome; Zygomycosis

2004

Other Studies

2 other study(ies) available for itraconazole and Ethmoid Sinusitis

Article	Year
[Successful treatment of invasive sinus aspergillosis with micafungin and itraconazole]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2006, Volume: 80, Issue:2 Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cavernous Sinus; Combined Modality Therapy; Echinocandins; Ethmoid Sinusitis; Female; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Orbit; Peptides, Cyclic; Sinusitis; Sphenoid Sinusitis	2006
[Drug treatment of invasive aspergillosis of the paranasal sinuses]. Laryngo- rhino- otologie, 1997, Volume: 76, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Therapy, Combination; Ethmoid Sinus; Ethmoid Sinusitis; Female; Humans; Itraconazole; Middle Aged; Tomography, X-Ray Computed	1997

Article

Year

[Successful treatment of invasive sinus aspergillosis with micafungin and itraconazole].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2006, Volume: 80, Issue:2

Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cavernous Sinus; Combined Modality Therapy; Echinocandins; Ethmoid Sinusitis; Female; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Orbit; Peptides, Cyclic; Sinusitis; Sphenoid Sinusitis

2006

[Drug treatment of invasive aspergillosis of the paranasal sinuses].

Laryngo- rhino- otologie, 1997, Volume: 76, Issue:1

Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Therapy, Combination; Ethmoid Sinus; Ethmoid Sinusitis; Female; Humans; Itraconazole; Middle Aged; Tomography, X-Ray Computed

1997